Janice Drew Selected Research

glycopyrronium tosylate

1/2021	Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis.
5/2020	Long-term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44-week open-label extension study.
8/2019	A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis.
2/2019	Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials.
1/2019	Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials.
1/2019	Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Janice Drew Research Topics

Disease

6	Hyperhidrosis 01/2021 - 01/2019
2	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2018 - 08/2018
1	Conjunctivitis 01/2020
1	Atopic Dermatitis (Atopic Eczema) 01/2020
1	Herpesviridae Infections (Herpesvirus Infection) 01/2020
1	Pruritus (Itching) 01/2020
1	Injection Site Reaction 01/2020
1	Obesity 08/2011
1	Neoplasms (Cancer) 03/2003

Drug/Important Bio-Agent (IBA)

6	glycopyrronium tosylateIBA 01/2021 - 01/2019
5	Cholinergic Antagonists (Anticholinergics)IBA 01/2021 - 01/2019
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2021 - 08/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2018 - 08/2018
2	Certolizumab Pegol FDA Link 08/2018 - 08/2018
2	Biological ProductsIBA 08/2018 - 08/2018
1	Interleukin-13IBA 01/2020
1	Immunoglobulin A (IgA)IBA 01/2020
1	lebrikizumabIBA 01/2020
1	Etanercept (Enbrel)FDA Link 08/2018
1	DNA (Deoxyribonucleic Acid)IBA 03/2003
1	AntioxidantsIBA 03/2003

Therapy/Procedure

1	Plant-Based Diet 08/2011